Neurology - Page 4

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of the sequential use of Mexidol and Mexidol Forte 250 in patients with chronic brain ischemia

Author:
Yu.V. Abramenko

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver, Russia

The modern concept of cognitive reserve

Author:

KOBERSKAYA N.N., TABEEVA G.R.

Place of publication:

NEUROLOGY. NEUROPSYCHIATRY. PSYCHOSOMATICS, 2019

Vascular depression and cognitive dysfunction

Author:

Bogolepova A.N.

Place of publication:

Neurology, neuropsychiatry, psychosomatics. 2019

The study of the effectiveness and safety of the use of Mexidol and Mexidol Forte 250 in patients with chronic brain ischemia

Author:
V.A. Kutashov, O.V. Ulyanova

FSBEI in Voronezh State Medical University named after N.N. Burdenko »Ministry of Health of Russia, Voronezh, Russia

The effectiveness and safety of the drug Mexol Forte 250 in the framework of consecutive therapy in patients with chronic brain ischemia

Author:
E.I. Chukanova, A.S. Chukanova

Department of Neurology, Neurosurgery and Medical Genetics of Faculty of Faculty of Faculty of FSBEI in "RNIMU named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Review of clinical recommendations for the treatment and prevention of ischemic stroke

Author:
A.I. Fedin, K.R. Badalyan

FSBEI in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

The prospects for the use of Mexidol for the treatment of patients suffering from neurosenate hearing loss and cerebrovascular failure

Author:
N.L. Kunelskaya, Yu.V. Levina, E.S. Yanyushkina, D.S. Ogorodnikov, E.V. Larionova

Combined use of Mexidol with known drugs

Author:
T.A. VORONIN, E.A. IVANOVA

FGBNU "Research Institute of Pharmacology named after V.V. Zakusova ”, Moscow, Russia

Evaluation of blood rheological parameters in patients with acute ischemic stroke using the drug Mexidol

Authors:

D.M. PLOTNIKOV ¹ , M.N. STEGMAIER ¹ , O.I. ALIEV ²

¹ Department of Neurology and Neurosurgery, Siberian State Medical University of the Ministry of Health of the Russian Federation, Tomsk, Russia;
² E.D. Goldberg Tomsk Research Institute of Pharmacology and Regenerative Therapy, National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia

Dynamics of cognitive functions during aging and their relationship with the level of education

Authors:

TITARENKO A.V., SHISHKIN S.V., SHCHERBAKOVA L.V., VEREVKIN E.G., HOLMES M., BOBAK M., MALYUTINA S.K.

Place of publication:

Neurology, neuropsychiatry, psychosomatics. 2018

Brainstorm, or therapy for cognitive impairments

Authors:
V.V. ZAKHAROV, E.YU. KALIMEEVA, N.V. VAKHNINA, T.G. FATEEVA

Department of Nervous System Diseases and Neurosurgery, I.M. Sechenov First Moscow State Medical University, Moscow

The effect of the use of Mexidol during the "therapeutic window" of ischemic stroke on the effectiveness of intravenous thrombolytic therapy

Authors:
K.S. Knny, T.V. Demin, L.B. Adaeva

GAUZ "Interregional Clinical and Diagnostic Center", Kazan, Russia

The effect of mexidol on changes in the lipid-phospholipid profile in acute cerebrovascular accidents in elderly patients

Author:
Yu.V. Abramenko

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver, Russia

The experience of using Mexidol in neurological practice

Authors:

O.A. Gromova ¹ , I.Yu. Torshin ¹ , L.V. Stakhovskaya ² , E.G. Pepelyaev ³ , V.A. Semenov ³ , A.G. Nazarenko ⁴

¹ Institute of Pharmacinformatics of the FIC "Informatics and management" of the Russian Academy of Sciences, Moscow, Russia;
² Research Institute of Cerebrovascular Pathology and Stroke FSBEI in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
³ FSBEI in Kemerovo State Medical University of the Ministry of Health of Russia, Kemerovo, Russia;
⁴ FGAU "National Medical Research Center for Neurosurgery named after Acad. N.N. Burdenko »Ministry of Health of Russia, Moscow, Russia

The effectiveness of Mexidol with transient ischemic attacks in the vertebral-baslar system in elderly patients with chronic brain ischemia

Author:
Yu.V. Abramenko

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver, Russia

Mono- and combination therapy with Mexidol in young patients with cerebral angiodystonia

Authors:
E.N. DYAKONOVA, V.V. MAKEROVA

Federal State Budgetary Educational Institution of Higher Education "Ivanovo State Medical Academy" of the Ministry of Health of the Russian Federation, Ivanovo, Russia

« 1 2 3 4 5 6 »